Collectively, this work suggests that drugs such as AZD5438 that inhibit both GSK3α/β and CDKs may confer protections to cells when they are under physiological stresses associated with the aetiology of neurodegenerative diseases such as PD and AD. Here, GSK3A is linked to Alzheimer disease.